Dr Scheideler joined NINDS Technology Development in 2005 as a Program Director for the Roadmap Molecular Libraries Initiative, with responsibility for its Assay Development for High Throughput Screening Program.  He came to the NIH with twelve years of international Drug Discovery experience, including roles as VP-Discovery Research at MDS Proteomics, Head of Neurobiology Research at SmithKline Beecham (then GSK), and as Principal Scientist and Program Head at Novo Nordisk.  Dr. Scheideler has held academic posts as Research Assistant Professor of Neurological Surgery at Albert Einstein College of Medicine and Postdoctoral Fellow in Biochemistry at Duke University Medical Center.  Dr. Scheideler earned a Ph.D. in Biochemistry from the University of Chicago, and a B.A. in Biochemistry and Molecular Biology from Northwestern University.